BRITTANY BAKER: Open Payments
NPI 1497121487 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,050 in 71 payments from 17 companies in 2025. Trend: 2023 $2,332 · 2024 $3,053 · 2025 $2,050
Food & beverage: $2,050
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $733 |
| ABBVIE INC. | 13 | $325 |
| Novartis Pharmaceuticals Corporation | 8 | $150 |
| Regeneron Healthcare Solutions, Inc. | 3 | $112 |
| Amgen Inc. | 4 | $96 |
| PFIZER INC. | 5 | $91 |
| UCB, Inc. | 3 | $81 |
| Botanix SB Inc | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
| LEO Pharma Inc. | 3 | $69 |
Products named: DUPIXENT, RINVOQ, SKYRIZI, COSENTYX, OTEZLA, CIBINQO, Bimzelx, SOFDRA.
Industry payments across GA — which companies pay providers there.
